← back to search

Laura Marandino

Azienda Ospedaliera Ospedale Maggiore · GB
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, and Urinary and Genital Oncology Studies.
h-index
31
citations
3,161
works
246
NIH funding
primary concept
Medicine
email

Recent publications

Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors
European Urology 2025cited by 42position: middledoi
Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM)
BMJ Oncology 2025cited by 10position: middledoi
Genetic Testing and Counselling for Hereditary Renal Carcinoma: What Do Clinicians Need to Know?
European Urology Open Science 2025cited by 2position: lastdoi
Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review
European Urology Open Science 2023cited by 55position: middledoi
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study
BMJ Oncology 2023cited by 25position: firstdoi
Single-port robotic partial nephrectomy: impact on perioperative outcomes and hospital stay
Therapeutic Advances in Urology 2023cited by 22position: middledoi
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives
Diagnostics 2023cited by 19position: middledoi
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy
European Urology Oncology 2023cited by 14position: middledoi
PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature
Journal of Clinical Medicine 2022cited by 41position: middledoi
Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group
World Journal of Urology 2022cited by 32position: middledoi
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy
European Journal of Cancer 2021cited by 183position: middledoi
A multicenter, retrospective study on impact of immunotherapy in urothelial carcinoma with bone metastases (Meet-Uro01 Study).
Journal of Clinical Oncology 2021cited by 1position: middledoi
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic
European Urology 2020cited by 140position: middledoi
767P Neutrophil-to-lymphocyte ratio (NLR) and systemic inflammation index (SII) as prognostic factors in advanced urinary tract carcinoma patients treated with atezolizumab: Subanalysis of the Italian population of the SAUL study
Annals of Oncology 2020cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Riccardo Campi · Virginia Commonwealth University6 papers (2022–2025) · 5 papers (2022–2025)Daniele Amparore · Università Campus Bio-Medico5 papers (2022–2025)Angela Pecoraro · McGill University Health Centre5 papers (2022–2025)Eduard Roussel · KU Leuven4 papers (2022–2023)Riccardo Bertolo · Rush University Medical Center4 papers (2022–2023)Stijn Muselaers · Second Military Medical University4 papers (2022–2023)Michele Marchioni · University of Padua4 papers (2022–2023)Nicola Pavan · Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo4 papers (2022–2023)Umberto Carbonara · Virginia Commonwealth University4 papers (2022–2023)Massimo Di Maïo · Azienda Ospedaliera Citta' della Salute e della Scienza di Torino3 papers (2021–2023) · 3 papers (2022–2023)Carlotta Palumbo · McGill University Health Centre2 papers (2023–2023) · 2 papers (2022–2022)Pietro Diana · Universitat de Barcelona2 papers (2022–2023)Alessandro Larcher · Vita-Salute San Raffaele University2 papers (2025–2025)Anna Caliò · Indiana University School of Medicine2 papers (2023–2023)Giuseppe Luigi Banna · University of Parma2 papers (2020–2021)Leonardo D. Borregales · Cornell University2 papers (2023–2023)Axel Bex · Dutch Cancer Society2 papers (2020–2025)